Cigna Corporation (CI) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CI, 263.47$ (piyasa değeri $70.38B) fiyatla Healthcare işi olan Cigna Corporation'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 43/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 8 Şub 2026Cigna Corporation (CI) Sağlık ve Boru Hattı Genel Bakışı
Cigna Corporation (CI) delivers integrated health solutions through its Evernorth and Cigna Healthcare segments, offering diverse medical, pharmacy, and behavioral health services; a notable research candidate driven by a focus on coordinated care and expanding its Medicare Advantage offerings, with a dividend yield of 2.07%.
Yatırım Tezi
Cigna Corporation presents a notable research candidate driven by its integrated healthcare model and strategic focus on expanding its Evernorth and Cigna Healthcare segments. With a P/E ratio of 13.04 and a dividend yield of 2.07%, the company offers a blend of value and income. Key value drivers include the growth of its Evernorth segment, which provides high-margin pharmacy and care management services, and the expansion of its Medicare Advantage offerings to capture a larger share of the senior healthcare market. Cigna's focus on coordinated care and digital health solutions positions it well to capitalize on the evolving healthcare landscape. The company's strong financial position, with a market cap of $78.01B, supports continued investment in growth initiatives and shareholder returns. Investors may want to evaluate Cigna for its potential to deliver sustainable earnings growth and long-term value.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market Cap of $78.01B reflects Cigna's significant presence and stability in the healthcare sector.
- P/E ratio of 13.04 suggests the company is reasonably valued compared to its earnings.
- Dividend Yield of 2.07% provides an attractive income stream for investors.
- Gross Margin of 9.5% indicates the profitability of Cigna's core services.
- Beta of 0.28 suggests the stock is significantly less volatile than the overall market.
Rakipler & Benzerleri
Güçlü Yönler
- Diversified business model with strong presence in insurance and pharmacy benefits management.
- Large and established customer base.
- Integrated platform enabling coordinated care and cost savings.
- Strong financial performance and cash flow generation.
Zayıflıklar
- Exposure to regulatory changes and healthcare reform.
- Dependence on government programs such as Medicare and Medicaid.
- Intense competition in the healthcare industry.
- Potential for rising healthcare costs to impact profitability.
Katalizörler
- Upcoming: Continued expansion of Evernorth services to drive revenue growth.
- Ongoing: Growth in Medicare Advantage membership and market share.
- Ongoing: Development and deployment of digital health solutions.
- Ongoing: Strategic acquisitions to expand capabilities and market reach.
Riskler
- Potential: Regulatory changes impacting the healthcare industry.
- Potential: Increased competition from other healthcare providers and insurers.
- Ongoing: Rising healthcare costs and utilization rates.
- Potential: Economic downturns impacting consumer spending on healthcare.
Büyüme Fırsatları
- Expansion of Evernorth Services: Cigna's Evernorth segment offers significant growth potential by expanding its pharmacy, benefits management, and care delivery services. The market for pharmacy benefit management is estimated to reach $600 billion by 2028. By leveraging its integrated platform and data analytics capabilities, Evernorth can capture a larger share of this market and drive revenue growth. Timeline: Ongoing.
- Medicare Advantage Growth: Cigna has a substantial opportunity to grow its Medicare Advantage business by targeting the increasing senior population. The Medicare Advantage market is projected to reach $400 billion by 2027. By offering competitive plans and expanding its geographic footprint, Cigna can attract more members and increase its market share. Timeline: Ongoing.
- Digital Health Solutions: Investing in digital health solutions, such as telehealth and remote monitoring, can improve patient outcomes and reduce costs. The digital health market is expected to reach $660 billion by 2025. Cigna can leverage its technology infrastructure and partnerships to develop innovative digital health offerings that enhance the customer experience and drive efficiency. Timeline: Ongoing.
- International Expansion: Cigna can expand its international presence by targeting emerging markets with growing healthcare needs. The global health insurance market is projected to reach $2.8 trillion by 2028. By entering new markets and offering tailored insurance products, Cigna can diversify its revenue streams and increase its global market share. Timeline: Ongoing.
- Strategic Acquisitions: Cigna can pursue strategic acquisitions to expand its capabilities and market reach. The healthcare industry is consolidating, and acquisitions can provide access to new technologies, customer segments, and geographic markets. By carefully evaluating potential targets and integrating acquired businesses, Cigna can accelerate its growth and enhance its competitive position. Timeline: Ongoing.
Fırsatlar
- Expansion into new geographic markets.
- Growth in Medicare Advantage and other government-sponsored programs.
- Development of innovative digital health solutions.
- Strategic acquisitions to expand capabilities and market reach.
Tehditler
- Increasing competition from other healthcare providers and insurers.
- Changes in government regulations and healthcare policy.
- Rising healthcare costs and utilization rates.
- Economic downturns impacting consumer spending on healthcare.
Rekabet Avantajları
- Strong brand recognition and reputation in the healthcare industry.
- Extensive network of healthcare providers and pharmacies.
- Integrated platform combining insurance, pharmacy benefits management, and care delivery.
- Significant scale and market share in key segments, like Medicare Advantage.
CI Hakkında
Founded in 1792 and headquartered in Bloomfield, Connecticut, The Cigna Group has evolved into a global health service leader. Initially focused on insurance, the company has expanded its offerings to include a comprehensive suite of health-related products and services. Cigna operates through two primary segments: Evernorth and Cigna Healthcare. The Evernorth segment provides coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions. This segment caters to health plans, employers, government organizations, and healthcare providers. Cigna Healthcare offers medical, pharmacy, behavioral health, dental, and vision products, alongside health advocacy programs. This segment serves insured and self-insured customers, provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans, and offers individual health insurance plans both on and off public exchanges. Furthermore, Cigna Healthcare extends its coverage internationally, providing healthcare benefits for mobile individuals and employees of multinational organizations. The company distributes its products through brokers, consultants, directly to employers, and via public and private exchanges. Cigna's commitment to innovation and customer-centric solutions positions it as a key player in the healthcare industry.
Ne Yaparlar
- Provides medical insurance plans to individuals and families.
- Offers pharmacy benefits management services.
- Delivers behavioral health services and support.
- Provides dental and vision insurance plans.
- Offers Medicare Advantage, Medicare Supplement, and Medicare Part D plans.
- Provides health care coverage in international markets.
- Offers health advocacy programs to help customers navigate the healthcare system.
İş Modeli
- Generates revenue through premiums from health insurance plans.
- Earns fees from pharmacy benefits management services.
- Receives payments for providing healthcare services through its network of providers.
- Manages risk by diversifying its customer base and geographic footprint.
Sektör Bağlamı
Cigna operates in the dynamic healthcare plans industry, which is characterized by increasing demand for coordinated care and cost-effective solutions. The industry is undergoing significant transformation driven by technological advancements, regulatory changes, and evolving consumer preferences. Cigna competes with major players like CVS, CNC, and smaller regional providers. The market is witnessing a shift towards value-based care models and personalized healthcare experiences. Cigna's integrated approach, combining pharmacy benefits management with healthcare services, positions it favorably in this competitive landscape. The global healthcare market is projected to continue growing, driven by aging populations and increasing prevalence of chronic diseases.
Kilit Müşteriler
- Individuals and families seeking health insurance coverage.
- Employers offering health benefits to their employees.
- Government organizations providing healthcare to their constituents.
- Healthcare providers seeking to improve patient outcomes and reduce costs.
Finansallar
Grafik & Bilgi
Cigna Corporation (CI) hisse senedi fiyatı: $263.47 (+0.00, +0.00%)
Son Haberler
-
Mark Cuban Calls $30,000 Corporate Healthcare Burden 'Insane,' Backs Bill To Break Up Big Medicine Giants UNH, CVS, CI
benzinga · 25 Mar 2026
-
The Cigna Group Foundation Supports More Than 8,000 Veterans Through Community-Led Housing Stability Programs
prnewswire.com · 24 Mar 2026
-
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026
Yahoo! Finance: CI News · 20 Mar 2026
-
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position
Yahoo! Finance: CI News · 20 Mar 2026
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
CI için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
Konsensüs hedefi: $332.62
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, CI'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Rakipler & Benzerleri
Son Haberler
Mark Cuban Calls $30,000 Corporate Healthcare Burden 'Insane,' Backs Bill To Break Up Big Medicine Giants UNH, CVS, CI
The Cigna Group Foundation Supports More Than 8,000 Veterans Through Community-Led Housing Stability Programs
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position
CI Hakkında Sıkça Sorulan Sorular
CI için değerlendirilmesi gereken temel faktörler nelerdir?
Cigna Corporation (CI) şu anda yapay zeka skoru 43/100, düşük puanı gösteriyor. Hisse 12.7x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) altında, potansiyel değer sinyali. Analist hedefi $332.62 ($263.47'dan +26%). Temel güçlü yan: Diversified business model with strong presence in insurance and pharmacy benefits management.. İzlenmesi gereken birincil risk: Potential: Regulatory changes impacting the healthcare industry.. Bu bir finansal tavsiye değildir.
CI MoonshotScore'u nedir?
CI şu anda MoonshotScore'da 43/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
CI verileri ne sıklıkla güncellenir?
CI fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler CI hakkında ne diyor?
Analistler, CI için $332.62 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($263.47) yukarı yönlü %26 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.
CI'a yatırım yapmanın riskleri nelerdir?
CI için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Regulatory changes impacting the healthcare industry.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
CI'ın P/E oranı nedir?
Cigna Corporation (CI)'nın son P/E oranı 12.7, ki bu da piyasa ortalamasının altında, bu da göreli değeri gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.
CI aşırı değerli mi, yoksa düşük değerli mi?
Cigna Corporation (CI)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 12.7. Analist hedefi $332.62 (mevcut fiyattan +26%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
CI'ın temettü verimi nedir?
Cigna Corporation (CI) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- The analysis is based on the provided data and current market conditions.
- Future events and market changes may impact the accuracy of the information.